These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 4606225)

  • 1. Anti-HL-A antibodies: Failure to correlate with renal allograft rejection.
    Callender CO; Simmons RL; Yunis EJ; Toledo-Pereyra LH; DeShazo MT; Najarian JS
    Surgery; 1974 Oct; 76(4):573-80. PubMed ID: 4606225
    [No Abstract]   [Full Text] [Related]  

  • 2. The new serology of histocompatibility testing and its significance in human renal transplantation.
    Braun WE
    Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083
    [No Abstract]   [Full Text] [Related]  

  • 3. HL-A matching and kidney-graft survival. Scandiatransplant report.
    Lancet; 1975 Feb; 1(7901):240-2. PubMed ID: 46386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early post-transplant function of 33 machine-preserved human cadaveric kidneys in children.
    Moore TC; Fine RN; Asch MJ; Berne TV; English TS
    Pediatrics; 1974 Dec; 54(6):773-8. PubMed ID: 4610500
    [No Abstract]   [Full Text] [Related]  

  • 5. Serologically defined HL-A antigens and long-term survival of cadaver kidney transplants. A joint analysis of 918 cases performed by France-Transplant and the London Transplant Group.
    Dausset J; Hors J; Busson M; Festenstein H; Oliver RT; Paris AM; Sachs JA
    N Engl J Med; 1974 May; 290(18):979-84. PubMed ID: 4594524
    [No Abstract]   [Full Text] [Related]  

  • 6. Is HL-A typing of clinical significance in cadaver renal transplantation?
    Belzer FO; Perkins HA; Fortmann JL; Kountz SL; Salvatierra O; Cochrum KC; Payne R
    Lancet; 1974 Apr; 1(7861):774-7. PubMed ID: 4132709
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between treatment-resistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens.
    Soulillou JP; Peyrat MA; Guenel J
    Lancet; 1978 Feb; 1(8060):354-6. PubMed ID: 75395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HL-A and kidney transplants: reexamination.
    Opelz G; Mickey MR; Terasaki PI
    Transplantation; 1974 Apr; 17(4):371-82. PubMed ID: 4604554
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group.
    Oliver RT; Sachs JA; Festenstein H; Pegrum GD; Moorhead JF
    Lancet; 1972 Dec; 2(7792):1381-5. PubMed ID: 4118684
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of HL-A hyplotypes and evolution of renal transplantation].
    Andreu J; Caralps A; Lloveras J; Benitez C; Masramón J; Guerra C
    Actas Urol Esp; 1977; 1(6):343-6. PubMed ID: 354344
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of histocompatibility on graft and patient survival in primary cadaver kidney transplantation.
    Storm B; Lindholm A
    Proc Eur Dial Transplant Assoc; 1972; 9():466-74. PubMed ID: 4589765
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monitoring cellular immunity in patients following renal transplantation].
    Górski A
    Pol Arch Med Wewn; 1972 Dec; 49(6):625-9. PubMed ID: 4566253
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical renal transplantation.
    Kountz SL
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):99-105. PubMed ID: 4612909
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved renal allograft survival using the mixed lymphocyte culture for selection of nonidentical living related donors.
    Riggio RR; Saal SD; Katz EB; Tapia L; White R; Chami J; Sheigh JS; Sullivan JF; Stenzel KH; Stubenbord WT; Whitsell JC; Rubin AL
    Trans Am Soc Artif Intern Organs; 1975; 21():90-5. PubMed ID: 1096421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRA, ELISA and CDC vs luminex screening.
    Muro M; Llorente S; Marín L; Moya-Quiles MR; Gonzalez-Soriano MJ; Prieto A; Gimeno L; Alvarez-López MR
    Nephrol Dial Transplant; 2005 Jan; 20(1):223-6. PubMed ID: 15632356
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of terminal kidney failure through transplantation].
    Dreikorn K; Röhl L
    Dtsch Med Wochenschr; 1974 Oct; 99(41):2043-6. PubMed ID: 4154187
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible rejection of an HL-A identical sibling renal allograft.
    d'Apice JF; Morris PJ; Kincaid-Smith P; Mathew TH; Marshall VC
    Med J Aust; 1976 Feb; 1(7):195-7. PubMed ID: 131902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HL-A typing and cadaver-kidney transplants.
    Jeannet M; De Weck A; Grob P; Horisberger B; Largiadèr F; Thiel G
    Transplant Proc; 1971 Jun; 3(2):1015-8. PubMed ID: 4944044
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular immune response in HL-A identical renal transplant recipients.
    Turnipseed WD; Folger MR; Cerilli J
    Surg Forum; 1973; 24():295-6. PubMed ID: 4618650
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of immunosuppressive therapy, HLA matching and donor age on long term cadaveric pediatric renal allograft survival.
    Groenewoud AF; Persijn GG; D'Amaro J; de Lange P; Cohen B
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1683-4. PubMed ID: 2652551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.